The Analgesic Efficacy of Lidocaine/Prilocaine (EMLA) cream during Dry Needling of an Active Myofascial Trigger Point in the Upper Trapezius Muscle: A Double-blind Randomized Controlled Trial

Phase 2

Completed

• Conditions: Pain during dry needling of an active Myofascial trigger Point in the Upper Trapezius Muscle; Pain during dry needling, pain from dry needling, pain associated with dry needling

• Registration Number: TCTR20240323002
• Lead Sponsor: Phramongkutklao Hospital Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2024-03-04
• Study Start: 2024-03-23
• Last Update Posted: 2024-08-19

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

1. Presented at least 1 active Myofascial trigger point in the upper trapezius, 2. Volunteers completing inform consent for their participation and dry needling procedure

Exclusion Criteria

1. Contraindication for dry needling included needle phobia, coagulopathy, thrombocytopenia, and psychiatric disorder, 2. History of analgesic or NSAIDs use in 24 hours, 3. Altered mental status or inability to comprehend question, 4. Contraindication for EMLA (lidocaine/prilocaine), 5. Pregnant women or breastfeeder, 6. denuded or broken skin over myofascial trigger point site

Study & Design

• Study Type: Interventional
• Study Design: Not specified